HemaCare Expands Its Product Portfolio with GMPrime™ Bone Marrow Aspirate
HEMACARE CORP (HEMA)
NASDAQ:AMEX Investor Relations:
hemacare.com/investors
Company Research
Source: Business Wire
Advancing cell and gene therapies with the highest quality GMP-compliant bone marrow starting material LOS ANGELES--(BUSINESS WIRE)--HemaCare Corporation (OTCMKTS: HEMA), a global leader and trusted brand in the customization of human-derived biological products and services for biomedical research, drug discovery, and cellular therapy process development, today announced that it has expanded its portfolio of GMP-compliant cellular material with the launch of GMPrime bone marrow aspirate. GMP-compliant bone marrow aspirate is in high demand globally and a critical starting material in the development of cell and gene therapies.Due to the extreme versatility of bone marrow-derived cells, invasive collection procedure, and limited access to qualified suppliers, sourcing sufficient GMP-compliant bone marrow is an immense challenge for the research, scientific, and clinical community. As a therapy moves from preclinical to clinical development, high-quality, consistent starting materia
Show less
Read more
Impact Snapshot
Event Time:
HEMA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HEMA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HEMA alerts
High impacting HEMACARE CORP news events
Weekly update
A roundup of the hottest topics